Skip to main navigation
Skip to search
Skip to main content
Sefako Makgatho Health Sciences University Home
Search content at Sefako Makgatho Health Sciences University
Home
Profiles
Departments
Research output
Activities
Understanding alzheimer disease
M. Vally
*
, F. Kathrada
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Understanding alzheimer disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acetylcholinesterase Inhibitors (AChEI)
75%
Alzheime's Disease
100%
Alzheimer's Disease
100%
Cognitive Decline
25%
Cognitive Deficits
25%
Cognitive Symptoms
25%
Disease Progression
25%
Disease-modifying Therapy
25%
Executive Dysfunction
25%
First-line Therapy
25%
Functional Decline
25%
Management Goals
25%
Management Interventions
25%
Medical Assessment
25%
Memantine
25%
Memory Impairment
25%
Moderate to Severe
25%
Monotherapy
25%
N-methyl-D-aspartate Receptor Antagonist
25%
Neurodegenerative Disorders
25%
Pharmacotherapy
25%
Symptom Relief
25%
Visuospatial Impairment
25%
Neuroscience
Acetylcholinesterase Inhibitor
100%
Alzheimer's Disease
100%
Aspartic Acid
33%
Cognitive Disorders
33%
Drug Therapy
33%
Executive Dysfunction
33%
Memantine
33%
Memory Disorder
33%
Neurodegenerative Disorder
33%
Treatment of Alzheimer's Disease
33%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Aspartic Acid
25%
Cholinesterase Inhibitor
75%
Cognitive Defect
25%
Diseases
75%
Memantine
25%
Memory Disorder
25%
Monotherapy
25%
Pathogenesis
25%
Pharmacotherapy
25%